Curated News
By: NewsRamp Editorial Staff
September 09, 2025

NRx Pharma Expands Mental Health Network with Florida Clinic Acquisition

Reddit Discuss on Substack View History of this news story on GitHub
Original Source

TLDR

  • NRx Pharmaceuticals gains competitive advantage by acquiring revenue-generating Dura Medical, expanding its Florida network to eight locations and enhancing its interventional psychiatry services portfolio.
  • NRx Pharmaceuticals' subsidiary HOPE Therapeutics acquired Dura Medical, which provides Ketamine Infusion Therapy and Transcranial Magnetic Stimulation for depression, PTSD, and chronic pain treatments.
  • This acquisition expands access to innovative mental health treatments, potentially improving lives for those suffering from depression, PTSD, and chronic pain conditions.
  • A U.S. Army veteran founded Dura Medical, now acquired by NRx Pharmaceuticals, offering cutting-edge treatments like Ketamine Infusion Therapy for mental health conditions.

Impact - Why it Matters

This acquisition represents a significant advancement in accessible mental healthcare, particularly for conditions like depression, PTSD, and suicidal ideation that affect millions nationwide. By expanding treatment networks and integrating innovative therapies like ketamine infusion and transcranial magnetic stimulation, this move could provide more patients with effective alternatives to traditional medications. For those struggling with treatment-resistant mental health conditions or chronic pain, this expansion means potentially life-changing treatments become more geographically accessible. The involvement of a clinical-stage pharmaceutical company also suggests potential for future integration of novel therapeutics into clinical practice, accelerating the translation of research into real-world treatments.

Summary

NRx Pharmaceuticals, a clinical-stage biopharmaceutical company trading on NASDAQ as NRXP, has announced a significant expansion through its subsidiary HOPE Therapeutics Inc. The company has successfully acquired Dura Medical, a revenue-generating provider of interventional psychiatry services operating in Naples and Ft. Myers, Florida. Founded in 2018 by U.S. Army veteran Stephen Durand, Dura Medical specializes in cutting-edge treatments for mental health conditions including depression, PTSD, suicidality, anxiety, and chronic pain through innovative therapies such as Ketamine Infusion Therapy, Transcranial Magnetic Stimulation, Spravato®, Stellate Ganglion Blocks, and traditional psychiatry.

This strategic acquisition, combined with pending deals for Neurospa TMS and Cohen and Associates, will expand HOPE's network to more than eight locations across Florida, creating one of the state's largest interventional psychiatry networks. Stephen Durand has been appointed Director of Florida Clinic Operations, bringing his veteran perspective and operational expertise to the expanded organization. NRx Pharmaceuticals is developing therapeutics based on its NMDA platform for central nervous system disorders, with NRX-100 (preservative-free intravenous ketamine) having received Fast Track Designation and NRX-101 (oral D-cycloserine/lurasidone) awarded Breakthrough Therapy Designation for treating suicidal bipolar depression.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, NRx Pharma Expands Mental Health Network with Florida Clinic Acquisition

blockchain registration record for this content.